Determination of Isavuconazole Susceptibility of Aspergillus and Candida Species by the EUCAST Method
出版年份 2013 全文链接
标题
Determination of Isavuconazole Susceptibility of Aspergillus and Candida Species by the EUCAST Method
作者
关键词
-
出版物
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 57, Issue 11, Pages 5426-5431
出版商
American Society for Microbiology
发表日期
2013-08-20
DOI
10.1128/aac.01111-13
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Multicenter Study of Isavuconazole MIC Distributions and Epidemiological Cutoff Values for Aspergillus spp. for the CLSI M38-A2 Broth Microdilution Method
- (2013) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- EUCAST Technical Note on Voriconazole and Aspergillus spp.
- (2013) W.W. Hope et al. CLINICAL MICROBIOLOGY AND INFECTION
- In Vitro Activities of Isavuconazole and Comparator Antifungal Agents Tested against a Global Collection of Opportunistic Yeasts and Molds
- (2013) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Single-Dose Phase I Study To Evaluate the Pharmacokinetics of Posaconazole in New Tablet and Capsule Formulations Relative to Oral Suspension
- (2012) Gopal Krishna et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)*
- (2012) Maiken C. Arendrup et al. CLINICAL MICROBIOLOGY AND INFECTION
- EUCAST Technical Note on Aspergillus and amphotericin B, itraconazole, and posaconazole
- (2012) M.C. Arendrup et al. CLINICAL MICROBIOLOGY AND INFECTION
- Evaluation of the pharmacokinetics and clinical utility of isavuconazole for treatment of invasive fungal infections
- (2012) Joanne Livermore et al. Expert Opinion on Drug Metabolism & Toxicology
- In vitro activity of isavuconazole against 208 Aspergillus flavus isolates in comparison with 7 other antifungal agents: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing
- (2011) Shivaprakash M. Rudramurthy et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs
- (2011) M. R. Shivaprakash et al. MYCOSES
- Acquired antifungal drug resistance inAspergillus fumigatus:epidemiology and detection
- (2010) Susan Julie Howard et al. MEDICAL MYCOLOGY
- In Vitro Activity of Isavuconazole against Aspergillus Species and Zygomycetes According to the Methodology of the European Committee on Antimicrobial Susceptibility Testing
- (2009) S. Perkhofer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Posaconazole Therapeutic Drug Monitoring: a Reference Laboratory Experience
- (2009) G. R. Thompson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Voriconazole Pharmacokinetics and Pharmacodynamics in Children
- (2009) Michael Neely et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetics and Absorption of Posaconazole Oral Suspension under Various Gastric Conditions in Healthy Volunteers
- (2008) G. Krishna et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Breakthrough Aspergillus fumigatus and Candida albicans Double Infection during Caspofungin Treatment: Laboratory Characteristics and Implication for Susceptibility Testing
- (2008) M. C. Arendrup et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Antifungal Activities of Isavuconazole (BAL4815), Voriconazole, and Fluconazole against 1,007 Isolates of Zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium Species
- (2008) J. Guinea et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications
- (2008) D. Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia–forming moulds
- (2008) CLINICAL MICROBIOLOGY AND INFECTION
- Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
- (2007) A. Pascual et al. CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now